| 1 |
Basics of Clinical Trials
- Definition der Klinischen Prüfung
- Phasen der Arzneimittelprüfung
- Anwendungsbeobachtungen
|
| 2 |
Good Clinical Practice
- Terminology
- Essential documents
- Archiving
- Audit
|
| 3 |
GCP Inspections |
| |
|
| 4 |
Ethics in Clinical Research
- Declaration of Helsinki
- Ethics approval process
- Informed consent
|
| 5 |
Investigational Medicinal Products Documentation |
| |
|
| 6 |
Relevant Items in Clinical Trials |
| |
|
| 7 |
Clinical Pharmacology
- Phase I studies - background
- Pharmacokinetics, ADME,
- Bioavailability
- Populationkinetics
- Pharmacogenetics
- Pharmacodynamics
- PK/PD-Correlation
|
| 8 |
Biometry in Clinical Research
- Statistische Auswertung
- Studiendesigns
- Multiples Testen
- Fallzahlbestimmung
- Datenmanagement
- Metaanalyse
- Subgruppenauswertung
- Interimsanalyse
- Epidemiologie
|
| 9 |
Clinical Trial Guidelines 1
- Women
- Elderly
- Children
- Vulnerable subjects
|
| 10 |
Regulatory Process in Clinical Development
- Paragraphen im AMG
- Vorlegung
- Überwachung, Audits, Inspektionen
- Europäische Besonderheiten
|
| 11 |
Clinical Trial Directive 2001/20/EC
- Chiral active substances
- Fixed combination medical products
|
| 12 |
Clinical Trials Guideline 2
- Vaccines
- Immunoglobulines
- Plasma-derived factors
- Recombinant factors
|
| 13 |
Clinical Development of Vaccines
- Background
- European public assessment reports
|
| 14 |
Clinical Development of Blood Products
- Background
- European public assessment reports
|
| 15 |
Clinical Trials Guidelines 3
- Drug Interactions
- QT-Interval prolongation
- Control group
- Modified release dosage forms
|
| 16 |
Safety in Clinical Trials
- Definitionen
- Causality assessment
- Anzeigepflicht, Meldungen
- Guidelines
- Stufenplan
|
| 17 |
Clinical Trial Guidelines 4 |
| |
|
| 18 |
Clinical Section of Application Dossier
- Directive 75/318/EEC
- Notice to applicants
- Common technical document
|
| 19 |
Clinical Trial Performance
|